A communication from the Department of Public Health (see Section 158 of Chapter 46 of the Acts of 2015) submitting its status update on the extended-release injectable naltrexone pilot program [copies of said report were forwarded to the committees on Ways and Means, Health Care Financing, Mental Health and Substance Use and Recovery, and Public Health as required by said law]
Bill status
introduced
1 of 4 stages cleared
Introduction
Nov 2019
Committee Review
Floor Vote
Governor
Introduced Nov 7, 2019
Last action Nov 7, 2019
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about HD 4613
Scope: MA
Hi! I can help you understand HD 4613. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline